You have 9 free searches left this month | for more free features.

Abraxane

Showing 1 - 25 of 531

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

Not yet recruiting
  • Immunotherapy;Envafolimab; Esophageal Cancer
  • (no location specified)
Apr 24, 2023

Pancreatic Tumors Trial in Shanghai (Sofantinib?abraxane?gemcitabine, Abraxane combined with gemcitabine)

Not yet recruiting
  • Pancreatic Neoplasms
  • Shanghai, China
    Fudan University ShangHai Cancer Center
Jul 31, 2023

Breast Cancer Trial in Nanjing (Pyrotinib, trastuzumab, abraxane)

Not yet recruiting
  • Breast Cancer
  • Pyrotinib, trastuzumab, abraxane
  • Nanjing, Jiangsu, China
    JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Dec 20, 2022

Metastatic Adenocarcinoma of the Pancreas Trial in Soeul (Minnelide)

Recruiting
  • Metastatic Adenocarcinoma of the Pancreas
  • Minnelide
  • Soeul, Korea, Republic of
    Samsung Medical Center
Dec 8, 2022

Advanced Breast Cancer Trial (SYHX2011 and Abraxane®)

Not yet recruiting
  • Advanced Breast Cancer
  • SYHX2011 and Abraxane®
  • (no location specified)
Mar 2, 2022

Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

Suspended
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Melanoma Trial in Houston (ABI-007, Ipilimumab, Phone Call)

Completed
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2022

Advanced Adenocarcinoma, Metastatic Adenocarcinoma Trial in Philadelphia (Hydroxychloroquine (HCQ), Gemcitabine, Abraxane)

Completed
  • Advanced Adenocarcinoma
  • Metastatic Adenocarcinoma
  • Hydroxychloroquine (HCQ)
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 29, 2022

Urothelial Carcinoma Trial in Ann Arbor (Pembrolizumab, Abraxane)

Active, not recruiting
  • Urothelial Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 15, 2021

Metastatic Breast Cancer Trial in New York (PU-H71, Nab-paclitaxel)

Completed
  • Metastatic Breast Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 17, 2021

Cord Compression Trial in Saint Louis (Radiation therapy, nab-Paclitaxel)

Terminated
  • Cord Compression
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 15, 2021

Breast Cancer Trial in United States (Mifepristone, Placebo, Nab-Paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +4 more
Mar 14, 2022

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,

Withdrawn
  • Triple Negative Breast Cancer
  • +4 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 2, 2022

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Patients With Stage IV or Recurrent Adenocarcinoma of the Lung Trial (Abraxane, Gemcitabine)

Completed
  • Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
  • (no location specified)
Sep 28, 2021

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Gastric Cancer in Situ, Pancreatic Cancers, Biliary Cancers Trial in Taipei (Oxaliplatin, Albumin-Bound Paclitaxel

Completed
  • Gastric Cancer in Situ
  • +2 more
  • Taipei, Taiwan
    Taiwan Cooperative Oncology Group, National Health Research Inst
Apr 5, 2022

HR+/HER2- Breast Cancer Trial (Tucidinostat, nab-paclitaxel)

Not yet recruiting
  • HR+/HER2- Breast Cancer
  • (no location specified)
Nov 21, 2022

Breast Cancer Trial in Houston, Sugar Land (T-DM1, Trastuzumab, Lapatinib)

Completed
  • Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Breast Cancer Trial in Boston (Pembrolizumab, Nab-Paclitaxel, Biopsy)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 22, 2022

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

Objective Response Rate Trial in Jinan (albumin-bound paclitaxe combined with bevacizumab biosimilar)

Recruiting
  • Objective Response Rate
  • albumin-bound paclitaxe combined with bevacizumab biosimilar
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Oct 7, 2021

Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

Completed
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 20, 2022

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023